• Home >>
  • Pharmaceuticals and Healthcare

Global mRNA Vaccines & Therapeutics Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2021-2027

  • ID : 1482757
  • Date : 22 Jan 2021
  • Region : Global
  • Pages :137

CHOOSE LICENCE TYPE

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global mRNA Vaccines & Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global mRNA Vaccines & Therapeutics market segmented into Standardization Of Cancer Treatment MRNA Vaccine Individualized Cancer Treatment MRNA Vaccine Infectious Disease Treatment MRNA Vaccine Infection Prevention MRNA Vaccine Based on the end-use, the global mRNA Vaccines & Therapeutics market classified into Hospital Clinic Others Based on geography, the global mRNA Vaccines & Therapeutics market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are Argos Therapeutics AstraZeneca Bayer BioNTech Boehringer Ingelheim CRISPR Therapeutics CureVac eTheRNA immunotherapies Ethris GlaxoSmithKline Vaccines In-Cell-Art Intellia Therapeutics Janssen Kernal Biologics MaxCyte Moderna Therapeutics Novartis PhaseRx Precision NanoSystems RaNa Therapeutics

Table of Contents 1 RESEARCH SCOPE 1.1 Research Product Definition 1.2 Research Segmentation 1.2.1 Product Type 1.2.2 Main product Type of Major Players 1.3 Demand Overview 1.4 Research Methodology 2 GLOBAL MRNA VACCINES & THERAPEUTICS INDUSTRY 2.1 Summary about mRNA Vaccines & Therapeutics Industry 2.2 mRNA Vaccines & Therapeutics Market Trends 2.2.1 mRNA Vaccines & Therapeutics Production & Consumption Trends 2.2.2 mRNA Vaccines & Therapeutics Demand Structure Trends 2.3 mRNA Vaccines & Therapeutics Cost & Price 3 MARKET DYNAMICS 3.1 Manufacturing & Purchasing Behavior in 2020 3.2 Market Development under the Impact of COVID-19 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunity 3.2.4 Risk 4 GLOBAL MARKET SEGMENTATION 4.1 Region Segmentation (2017 to 2021f) 4.1.1 North America (U.S., Canada and Mexico) 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe) 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific) 4.1.4 South America (Brazil,, Argentina, Rest of Latin America) 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) 4.2 Product Type Segmentation (2017 to 2021f) 4.2.1 Standardization Of Cancer Treatment MRNA Vaccine 4.2.2 Individualized Cancer Treatment MRNA Vaccine 4.2.3 Infectious Disease Treatment MRNA Vaccine 4.2.4 Infection Prevention MRNA Vaccine 4.3 Consumption Segmentation (2017 to 2021f) 4.3.1 Hospital 4.3.2 Clinic 4.3.3 Others 5 NORTH AMERICA MARKET SEGMENT 5.1 Region Segmentation (2017 to 2021f) 5.1.1 U.S. 5.1.2 Canada 5.1.3 Mexico 5.2 Product Type Segmentation (2017 to 2021f) 5.2.1 Standardization Of Cancer Treatment MRNA Vaccine 5.2.2 Individualized Cancer Treatment MRNA Vaccine 5.2.3 Infectious Disease Treatment MRNA Vaccine 5.2.4 Infection Prevention MRNA Vaccine 5.3 Consumption Segmentation (2017 to 2021f) 5.3.1 Hospital 5.3.2 Clinic 5.3.3 Others 5.4 Impact of COVID-19 in North America 6 EUROPE MARKET SEGMENTATION 6.1 Region Segmentation (2017 to 2021f) 6.1.1 Germany 6.1.2 UK 6.1.3 France 6.1.4 Italy 6.1.5 Rest of Europe 6.2 Product Type Segmentation (2017 to 2021f) 6.2.1 Standardization Of Cancer Treatment MRNA Vaccine 6.2.2 Individualized Cancer Treatment MRNA Vaccine 6.2.3 Infectious Disease Treatment MRNA Vaccine 6.2.4 Infection Prevention MRNA Vaccine 6.3 Consumption Segmentation (2017 to 2021f) 6.3.1 Hospital 6.3.2 Clinic 6.3.3 Others 6.4 Impact of COVID-19 in Europe 7 ASIA-PACIFIC MARKET SEGMENTATION 7.1 Region Segmentation (2017 to 2021f) 7.1.1 China 7.1.2 India 7.1.3 Japan 7.1.4 South Korea 7.1.5 Southeast Asia 7.1.6 Australia 7.1.7 Rest of Asia Pacific 7.2 Product Type Segmentation (2017 to 2021f) 7.2.1 Standardization Of Cancer Treatment MRNA Vaccine 7.2.2 Individualized Cancer Treatment MRNA Vaccine 7.2.3 Infectious Disease Treatment MRNA Vaccine 7.2.4 Infection Prevention MRNA Vaccine 7.3 Consumption Segmentation (2017 to 2021f) 7.3.1 Hospital 7.3.2 Clinic 7.3.3 Others 7.4 Impact of COVID-19 in Europe 8 SOUTH AMERICA MARKET SEGMENTATION 8.1 Region Segmentation (2017 to 2021f) 8.1.1 Brazil 8.1.2 Argentina 8.1.3 Rest of Latin America 8.2 Product Type Segmentation (2017 to 2021f) 8.2.1 Standardization Of Cancer Treatment MRNA Vaccine 8.2.2 Individualized Cancer Treatment MRNA Vaccine 8.2.3 Infectious Disease Treatment MRNA Vaccine 8.2.4 Infection Prevention MRNA Vaccine 8.3 Consumption Segmentation (2017 to 2021f) 8.3.1 Hospital 8.3.2 Clinic 8.3.3 Others 8.4 Impact of COVID-19 in Europe 9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION 9.1 Region Segmentation (2017 to 2021f) 9.1.1 GCC 9.1.2 North Africa 9.1.3 South Africa 9.1.4 Rest of Middle East and Africa 9.2 Product Type Segmentation (2017 to 2021f) 9.2.1 Standardization Of Cancer Treatment MRNA Vaccine 9.2.2 Individualized Cancer Treatment MRNA Vaccine 9.2.3 Infectious Disease Treatment MRNA Vaccine 9.2.4 Infection Prevention MRNA Vaccine 9.3 Consumption Segmentation (2017 to 2021f) 9.3.1 Hospital 9.3.2 Clinic 9.3.3 Others 9.4 Impact of COVID-19 in Europe 10 COMPETITION OF MAJOR PLAYERS 10.1 Brief Introduction of Major Players 10.1.1 Argos Therapeutics 10.1.2 AstraZeneca 10.1.3 Bayer 10.1.4 BioNTech 10.1.5 Boehringer Ingelheim 10.1.6 CRISPR Therapeutics 10.1.7 CureVac 10.1.8 eTheRNA immunotherapies 10.1.9 Ethris 10.1.10 GlaxoSmithKline Vaccines 10.1.11 In-Cell-Art 10.1.12 Intellia Therapeutics 10.1.13 Janssen 10.1.14 Kernal Biologics 10.1.15 MaxCyte 10.1.16 Moderna Therapeutics 10.1.17 Novartis 10.1.18 PhaseRx 10.1.19 Precision NanoSystems 10.1.20 RaNa Therapeutics 10.2 mRNA Vaccines & Therapeutics Sales Date of Major Players (2017-2020e) 10.2.1 Argos Therapeutics 10.2.2 AstraZeneca 10.2.3 Bayer 10.2.4 BioNTech 10.2.5 Boehringer Ingelheim 10.2.6 CRISPR Therapeutics 10.2.7 CureVac 10.2.8 eTheRNA immunotherapies 10.2.9 Ethris 10.2.10 GlaxoSmithKline Vaccines 10.2.11 In-Cell-Art 10.2.12 Intellia Therapeutics 10.2.13 Janssen 10.2.14 Kernal Biologics 10.2.15 MaxCyte 10.2.16 Moderna Therapeutics 10.2.17 Novartis 10.2.18 PhaseRx 10.2.19 Precision NanoSystems 10.2.20 RaNa Therapeutics 10.3 Market Distribution of Major Players 10.4 Global Competition Segmentation 11 MARKET FORECAST 11.1 Forecast by Region 11.2 Forecast by Demand 11.3 Environment Forecast 11.3.1 Impact of COVID-19 11.3.2 Geopolitics Overview 11.3.3 Economic Overview of Major Countries 12 REPORT SUMMARY STATEMENT

Table mRNA Vaccines & Therapeutics Product Type Overview Table mRNA Vaccines & Therapeutics Product Type Market Share List Table mRNA Vaccines & Therapeutics Product Type of Major Players Table Brief Introduction of Argos Therapeutics Table Brief Introduction of AstraZeneca Table Brief Introduction of Bayer Table Brief Introduction of BioNTech Table Brief Introduction of Boehringer Ingelheim Table Brief Introduction of CRISPR Therapeutics Table Brief Introduction of CureVac Table Brief Introduction of eTheRNA immunotherapies Table Brief Introduction of Ethris Table Brief Introduction of GlaxoSmithKline Vaccines Table Brief Introduction of In-Cell-Art Table Brief Introduction of Intellia Therapeutics Table Brief Introduction of Janssen Table Brief Introduction of Kernal Biologics Table Brief Introduction of MaxCyte Table Brief Introduction of Moderna Therapeutics Table Brief Introduction of Novartis Table Brief Introduction of PhaseRx Table Brief Introduction of Precision NanoSystems Table Brief Introduction of RaNa Therapeutics Table Products & Services of Argos Therapeutics Table Products & Services of AstraZeneca Table Products & Services of Bayer Table Products & Services of BioNTech Table Products & Services of Boehringer Ingelheim Table Products & Services of CRISPR Therapeutics Table Products & Services of CureVac Table Products & Services of eTheRNA immunotherapies Table Products & Services of Ethris Table Products & Services of GlaxoSmithKline Vaccines Table Products & Services of In-Cell-Art Table Products & Services of Intellia Therapeutics Table Products & Services of Janssen Table Products & Services of Kernal Biologics Table Products & Services of MaxCyte Table Products & Services of Moderna Therapeutics Table Products & Services of Novartis Table Products & Services of PhaseRx Table Products & Services of Precision NanoSystems Table Products & Services of RaNa Therapeutics Table Market Distribution of Major Players Table Global Major Players Sales Revenue (Million USD) 2017-2020e Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e Table Global mRNA Vaccines & Therapeutics Market Forecast (Million USD) by Region 2021f-2026f Table Global mRNA Vaccines & Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f Table Global mRNA Vaccines & Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f Table Global mRNA Vaccines & Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f Figure Global mRNA Vaccines & Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million) Figure Global mRNA Vaccines & Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million) Figure Global mRNA Vaccines & Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million) Figure Global mRNA Vaccines & Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million) Figure Global mRNA Vaccines & Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million) Figure Global mRNA Vaccines & Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million) Figure Global mRNA Vaccines & Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million) Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Standardization Of Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Individualized Cancer Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infectious Disease Treatment MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Infection Prevention MRNA Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Argos Therapeutics 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of AstraZeneca 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Bayer 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of BioNTech 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Boehringer Ingelheim 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of CRISPR Therapeutics 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of CureVac 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of eTheRNA immunotherapies 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Ethris 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of GlaxoSmithKline Vaccines 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of In-Cell-Art 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Intellia Therapeutics 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Janssen 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Kernal Biologics 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of MaxCyte 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Moderna Therapeutics 2017-2020e Figure mRNA Vaccines & Therapeutics Sales Revenue (Million USD) of Novartis 2017-2020e Figure Sales Revenue (Million USD) of PhaseRx 2017-2020e Figure Sales Revenue (Million USD) of Precision NanoSystems 2017-2020e Figure Sales Revenue (Million USD) of RaNa Therapeutics 2017-2020e

CHOOSE LICENCE TYPE

TESTIMONIALS

What amazed me most was the professionalism and client satisfaction provided by Garner Insights. Their responses were quick and actioned on immediately.

Sr. Manager
A UK based manufacturing firm

I would like to thank the team at Garner Insights, you guys made my job so easier with your spoon fed service and quality market study.

President
At a US based consulting firm

The team of Garner Insights solved my queries in a timely fashion and gracefully. I have purchased reports from them a few times now and they never cease to impress with their highly intellectual team.

Marketing Manager
At a Fortune 100 pharmaceutical firm

I had some issues with the payment gateway and almost the immediate second I get a call from one of the enthusiastic sales member who guided me throughout the process and also reassured me of the next steps.

A Consultant
At a German based retail firm

The quality of data encompassed in the report was very useful for me in my marketing strategy needs

Director of Marketing
At a US based Manufacturing firm

What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology